Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections

Area of Science:

• Microbiology
• Infectious Diseases
• Cystic Fibrosis Research

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) is common in cystic fibrosis (CF) patients, leading to poor outcomes.
• Chronic MRSA infections in CF are difficult to eradicate with antibiotics.
• Antibiotic tolerance, the ability to survive antibiotics without resistance, is a potential factor in treatment failure.

Purpose of the Study:

• To investigate if bacterial phenotypes, including antibiotic tolerance, can predict clinical outcomes of MRSA infections in CF patients.
• To explore the relationship between vancomycin tolerance and MRSA clearance.
• To identify factors influencing MRSA infection persistence in CF.

Main Methods:

• Characterized 90 MRSA isolates from 57 CF patients for growth rates, biofilm formation, hemolysis, pigmentation, and vancomycin tolerance.
• Assessed MRSA isolates from acute and early infection stages.
• Correlated phenotypic traits and antibiotic tolerance with MRSA clearance.

Main Results:

• MRSA isolates exhibited biofilm production and delta-hemolysis (indicating agr activity).
• 24% of isolates showed strong vancomycin tolerance, unassociated with intermediate susceptibility.
• No association was found between measured phenotypic traits, antibiotic tolerance, and MRSA clearance.

Conclusions:

• Bacterial phenotypes and vancomycin tolerance alone do not predict MRSA clearance in CF patients.
• Additional factors beyond antibiotic tolerance are crucial for understanding and predicting MRSA infection outcomes in CF.
• Further research is needed to identify key predictors for MRSA eradication strategies in CF.